Download PDF
Semin Thromb Hemost 2003; 29(3): 309-316
DOI: 10.1055/s-2003-40969
Copyright © 2003 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Noninvasive Assessment of Neoplastic Angiogenesis: The Role of Magnetic Resonance Imaging

Majed Abu-Hajir1 , Scott D. Rand2 , Hendrikus G. Krouwer3 , Kathleen M. Schmainda2,4
  • 1Assistant Professor of Medicine, Division of Neoplastic Diseases and Related Disorders, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin
  • 2Department of Radiology, Medical College of Wisconsin, Milwaukee, Wisconsin
  • 3Department of Neurology, Medical College of Wisconsin, Milwaukee, Wisconsin
  • 4Biosphysics Research Institute, Medical College of Wisconsin, Milwaukee, Wisconsin
Further Information

Publication History

Publication Date:
30 July 2003 (online)

    Permissions and Reprints

ABSTRACT

The study of the effect of angiogenesis inhibitors on tumors is limited by our ability to assess their effect in vivo. Approaches that are currently employed have significant limitations. An ideal approach would employ a widely available noninvasive technology that can be used repeatedly to assess the antiangiogenic effect on the same lesions in a serial fashion. We describe here a specialized magnetic resonance imaging (MRI)-based technique that we employ in the study of angiogenesis of brain tumors. This technique, called relative cerebral blood volume (rCBV) mapping, is a noninvasive technique that adds just a few minutes to the conventional MRI study of a human brain tumor in the clinical setting. We hope that such a technique will serve as a model for developing new imaging techniques for the assessment of angiogenesis modulation in other tumor settings. We describe the technical basis and some examples of using rCBV mapping in neoplastic angiogenesis assessment, including a discussion of current limitations and future directions.

KEYWORDS

Angiogenesis - magnetic resonance imaging - tumor imaging - glioblastoma multiforme

REFERENCES

  • 1 Folkman J, Mulliken J B, Ezekowitz R A. Antiangiogenic Therapy of Hemangiomas with Interferon-Alpha. London: Chapman & Hall Medical 1997
    Google Scholar
  • 2 Weidner N, Semle J P, Welch W R, Folkman J. Tumor angiogeness and metastasis-correlation in invasive breast carcinoma.  N Engl J Med . 1991;  324 1-8
    CrossrefPubMedGoogle Scholar
  • 3 Gasparini G, Folkman J. Basic and clinical research on angiogenesis.  Eur J Cancer . 1996;  32A 2379-2540
    PubMedGoogle Scholar
  • 4 Bossi P, Viale G, Lee A K. et al . Angiogenesis in colorectal tumors: microvessel quantitation in adenomas and carcinomas with clinicopathological correlations.  Cancer Res . 1995;  55 5049-5053
    PubMedGoogle Scholar
  • 5 Sarbia M, Bittinger F, Porschen R. et al . Tumor vascularization and prognosis in squamous cell carcinomas of the esophagus.  Anticancer Res . 1996;  15 2117-2122
    PubMedGoogle Scholar
  • 6 Ellis L M, Walker R A, Gasparini G. Is determination of angiogenic activity in human tumours clinical useful?.  Eur J Cancer . 1998;  34 609-618
    CrossrefPubMedGoogle Scholar
  • 7 Lindner D J, Borden E C. Effects of tamoxifen and interferon-beta or the combination on tumor-induced angiogenesis.  Int J Cancer . 1997;  71 456-461
    CrossrefPubMedGoogle Scholar
  • 8 Poptani H, Puumalainen A M, Grohn O H. et al . Monitoring thymidine kinase and ganciclovir-induced changes in rat malignant glioma in vivo by nuclear magnetic resonance imaging.  Cancer Gene Ther . 1998;  5 101-109
    PubMedGoogle Scholar
  • 9 Rosen B R, Belliveau J W, Vevea J M, Brady T J. Perfusion imaging with NMR contrast agents.  Magn Reson Med . 1990;  14 249-265
    CrossrefPubMedGoogle Scholar
  • 10 Belliveau J W, Kennedy D N, McKinstry R C, Buchbinder B R, Weisskoff R M. Functional mapping of the human visual cortex by magnetic resonance imaging.  Science . 1991;  254 621-768
    PubMedGoogle Scholar
  • 11 Aronen H J, Cohen M S, Belliveau J W, Fordham J A, Rosen B R. Ultrafast imaging of brain tumors.  Top Magn Reson Imaging . 1993;  5 14-24
    PubMedGoogle Scholar
  • 12 Maeda M, Itoh S, Kimura H. et al . Tumor vascularity in the brain: evaluation with dynamic susceptibility-contrast MR imaging.  Radiology . 1993;  189 233-238
    PubMedGoogle Scholar
  • 13 Aronen H J, Gazit I E, Louis D N. et al . Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings.  Radiology . 1994;  191 41-51
    PubMedGoogle Scholar
  • 14 Guckel F, Brix G, Rempp K. et al . Assessment of cerebral blood volume with dynamic susceptibility contrast enhanced gradient-echo imaging.  J Comput Assist Tomogr . 1994;  18 344-351
    PubMedGoogle Scholar
  • 15 Bruening R, Kwong K K, Vevea M J. et al . Echo-planar MR determination of relative cerebral blood volume in human brain tumors: TI versus T2 weighting.  Am J Neuroradiol . 1996;  17 831-840
    PubMedGoogle Scholar
  • 16 Siegal T, Rubinstein R, Tzuk-Shina T, Gomori J M. Utility of relative cerebral blood volume mapping derived from perfusion magnetic resonance imaging in the routine follow up of brain tumors.  J Neurosurg . 1997;  86 22-27
    PubMedGoogle Scholar
  • 17 Boxerman J L, Rosen B R, Weisskoff R M. Signal-to-noise analysis of cerebral blood volume maps from dynamic NMR imaging studies.  J Magn Reson Imaging . 1997;  7 528-537
    PubMedGoogle Scholar
  • 18 Hacklander T, Reichenbach J R, Modder U. Comparison of cerebral blood volume measurements using the TI and T2* methods in normal human brains and brain tumors.  J Comput Assist Tomogr . 1997;  21 857-866
    CrossrefPubMedGoogle Scholar
  • 19 Hou L, Yang Y, Mattay V S, Frank J A, Duyn J H. Optimization of fast acquisition methods for whole-brain relative cerebral blood volume (rCBV) mapping with susceptibility contrast agents.  J Magn Reson Imaging . 1999;  9 233-239
    CrossrefPubMedGoogle Scholar
  • 20 Donahue K M, Krouwer H GJ, Rand S D. et al . Utility of simultaneously acquired gradient-echo and spin-echo cerebral blood volume and morphology maps in brain tumor patients.  Magn Reson Med . 2000;  43 845-853
    CrossrefPubMedGoogle Scholar
  • 21 Zhu X P, Li K L, Kamaly-Asl I D. et al . Quantification of endothelial permeability, leakage space, and blood volume in brain tumors using combined TI and T2* contrast-enhanced dynamic MR imaging.  J Magn Reson Imaging . 2000;  11 575-585
    CrossrefPubMedGoogle Scholar
  • 22 Aronen H J, Pardo F S, Kennedy D N. et al . High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas.  Clin Cancer Res . 2000;  6 2189-2200
    PubMedGoogle Scholar
  • 23 Sugahara T, Korogi Y, Kochi M, Ushio Y, Takahashi M. Perfusion-sensitive MR imaging of gliomas: comparison between gradient-echo and spin-echo echo-planar imaging techniques.  Am J Neuroradiol . 2001;  22 1306-1315
    PubMedGoogle Scholar
  • 24 Sugahara T, Jorogi Y, Tomiguchi S. et al . Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue.  Am J Neuroradiol . 2000;  21 901-909
    PubMedGoogle Scholar
  • 25 Fuss M, Wenz F, Essig M. et al . Tumor angiogenesis of low-grade astrocytomas measured by dynamic susceptibility contrast-enhanced MRI (DSC-MRI) is predictive of local tumor control after radiation therapy.  Int J Radiat Oncol . 2001;  51 478-482
    CrossrefPubMedGoogle Scholar
  • 26 Hacklander T, Hofer M, Reichenbach J R. et al . Cerebral blood volume maps with dynamic contrast-enhanced TI-weighted FLASH imaging: normal values and preliminary clinical results.  J Comput Assist Tomogr . 1996;  20 532-539
    CrossrefPubMedGoogle Scholar
  • 27 Boxerman J L, Hamberg L M, Rosen B R, Weisskoff R M. MR contrast due to intravascular magnetic susceptibility pertubations.  Magn Reson Med . 1995;  34 555-566
    PubMedGoogle Scholar
  • 28 Dennie J, Mandeville J B, Boxerman J L. et al . NMR imaging of changes in vascular morphology due to tumor angiogenesis.  Magn Reson Med . 1998;  40 793-799
    PubMedGoogle Scholar
  • 29 Heiland S, Benner T, Debus J. et al . Simultaneous assessment of cerebral hemodynamics and contrast agent uptake in lesions with disrupted blood brain barrier.  Magn Reson Imaging . 1999;  17 21-27
    PubMedGoogle Scholar
  • 30 Ostergaard L, Hochberg F H, Rabinov J D. et al . Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors.  J Neurosurg . 1999;  90 300-305
    PubMedGoogle Scholar
  • 31 Rand S D, Donahue-Schmainda K M, Pathak A P. et al .Effects of dexamethasone on rat 9L gliosarcoma model vasculature measured with MR derived relative cerebral blood volume maps and validated with histologic analysis. In: Proceedings of the 40th Annual Meeting of the American Society of Neuroradiology; May 13-17, 2002; Vancouver, Canada
    Google Scholar
  • 32 Gossmann A, Helbich T H, Kuriyama N. et al . Dynamic contrast-enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in xenograft model of gliobalstoma multiforme.  J Magn Reson Imaging . 2002;  15 233-240
    CrossrefPubMedGoogle Scholar
  • 33 Drew P J, Buckley D, Mussurakis S. et al . In vivo quantitative analysis of tumour angiogenesis with dynamic contrast-enhanced magnetic resonance mammography (Abst).  Br J Surg . 1997;  84(Suppl 1) 7
    PubMedGoogle Scholar
      >